These compounds may interact with:
5-hydroxytryptamine receptor 2A
Potentially involved in: alcohol dependence; seasonal affective disorder; acquired metabolic disease; kidney cancer; substance-related disorder; carcinoma; schizophrenia; obsessive-compulsive disorder; major depressive disorder; bipolar disorder; panic disorder; hypoactive sexual desire disorder; schizoaffective disorder; anorexia nervosa; attention deficit hyperactivity disorder; parkinson's disease; personality disorder; generalized anxiety disorder; leber congenital amaurosis 15; autistic disorder
Disease data sourced from Pharos.